OTE welcomes new editor

Article

Ophthalmology Times Europe founding editor, Fedra Pavlou, is to become Editor-in-Chief of Pharmaceutical Technology Europe, another of Advanstar's publications. Pamela Brook joins the team as editor of OTE, with immediate effect.

Ophthalmology Times Europe founding editor, Fedra Pavlou, is to become Editor-in-Chief of Pharmaceutical Technology Europe, another of Advanstar's publications. Pamela Brook joins the team as editor of OTE, with immediate effect. However, the OTE portfolio will continue to benefit from Fedra's expertise, as she will continue to contribute her valuable knowledge at various times throughout this coming year. Commenting on the changes Fedra said: "It has been a pleasure to be involved in such an exciting and rewarding industry and thank you to all our readers for your input, feedback and kind words since our launch."

Incoming editor, Pamela Brook said: "No reader of OTE can doubt that it is Fedra, and her team's, hard work, commitment and extensive knowledge of the industry that has made Ophthalmology Times Europe the success it is today. We all wish her every success in her new role. In turn, I am extremely pleased to be joining OTE at what promises to be both a changing and, subsequently, challenging time."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.